☰

Alisha A. Mohamed-Hadley, Ph.D. - Publications

Affiliations: 
2011 Molecular Biology and Genetics Temple University, Philadelphia, PA, United States 
Area:
Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Liebermann DA, Tront JS, Sha X, Mukherjee K, Mohamed-Hadley A, Hoffman B. Gadd45 stress sensors in malignancy and leukemia. Critical Reviews in Oncogenesis. 16: 129-40. PMID 22150313 DOI: 10.1615/Critrevoncog.V16.I1-2.120  0.574
2010 Mohamed-Hadley AA, Liebermann D. Stress Response Gadd45a Gene Functions as Tumor Suppressor In MYC Expressing Myeloid Cells Modulating Apoptosis and Cytokine Receptor Expression. Blood. 116: 1556-1556. DOI: 10.1182/Blood.V116.21.1556.1556  0.743
2010 Hoffman B, Mohamed-Hadley A, Liebermann D. Abstract 3099: Stress response gadd45a gene as tumor suppressor in MYC expressing myeloid cells is cytokine specific Cancer Research. 70: 3099-3099. DOI: 10.1158/1538-7445.Am10-3099  0.74
2009 Mohamed-Hadley AA, Liebermann DA, Hoffman B. Stress Response Gadd45a Gene as Tumor Suppressor in MYC Expressing Myeloid Cells Is Cytokine Specific. Blood. 114: 1481-1481. DOI: 10.1182/Blood.V114.22.1481.1481  0.761
2007 Mohamed-Hadley A, Gibbs JD, Liebermann DA, Hoffman B. Gadd45a Behaves as a Tumor Suppressor and Gadd45b Behaves as an Oncogene in myc-Mediated Block in Myeloid Differentiation. Blood. 110: 4163-4163. DOI: 10.1182/Blood.V110.11.4163.4163  0.605
2007 Gibbs JD, Mohamed-Hadley A, Liebermann DA, Hoffman B. Gadd45 Genes Participate in Myeloid Cell Fate Determination. Blood. 110: 4043-4043. DOI: 10.1182/Blood.V110.11.4043.4043  0.594
2005 Benencia F, Courrèges MC, Conejo-García JR, Mohamed-Hadley A, Zhang L, Buckanovich RJ, Carroll R, Fraser N, Coukos G. HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 789-802. PMID 15925544 DOI: 10.1016/J.Ymthe.2005.03.026  0.344
2003 Conejo-Garcia JR, Benencia F, Courreges MC, Khang E, Zhang L, Mohamed-Hadley A, Vinocur JM, Buckanovich RJ, Thompson CB, Levine B, Coukos G. Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells. Cancer Biology & Therapy. 2: 446-51. PMID 14508119 DOI: 10.4161/Cbt.2.4.479  0.441
Show low-probability matches.